R Pachocki

Health Professions · Health Sciences

7h-index193citations37works0.02yr avg
OpenAlex↗Google Scholar↗

Accepting Students?

No reports yet. Know if this professor is taking students?

Research Topics

Global Health Care Issues(7), Health Systems, Economic Evaluations, Quality of Life(6), Cardiac Imaging and Diagnostics(3), Cardiovascular Function and Risk Factors(3), Pharmaceutical Economics and Policy(3)

Publications37 total

PCV58 COSTS OF CORONARY ARTERY DISEASE (CAD) IN POLAND
Value in Health·2008Open Access
PCV45 COST OF CHRONIC VENOUS INSUFFICIENCY (CVI) IN POLAND
Value in Health·2006
PCV58 THE ROLE OF ECONOMIC FACTORS IN THERAPEUTIC DECISION MAKING CONCERNING TREATMENT OF CORONARY ARTERY DISEASE IN POLAND
Value in Health·2006Open Access
PCN28 SHOULD FOTEMUSTINE BE USED AS THE FIRST LINE TREATMENT
Value in Health·2006
Rilmenidine – its antihypertensive efficacy, safety and impact on quality of life in perimenopausal women with mild to moderate essential hypertension
Blood Pressure·2006· 5 cited
PDB43 SHOULD WE LOOK FOR A NEWAPPROACH IN DIABETES MELLITUS (DM) MANAGEMENT? IS IT A COST-EFFECTIVE STRATEGY IN THE POLISH SETTING?
Value in Health·2005
PCV56 EVALUATION OF COSTS RELATED TO HYPERTENSION IN PATIENTS WITH CONCOMITANT DISEASES IN POLAND
Value in Health·2005Open Access
PCV55 EVALUATION OF COSTS RELATED TO HYPERTENSION IN PATIENTS WITH UNCONTROLLED HYPERTENSION IN POLAND
Value in Health·2005
PRS7 COST-EFFECTIVENESS OF FENSPIRIDE IN ADULTS WITH CHRONIC BRONCHITIS EXACERBATIONS IN POLAND
Value in Health·2005Open Access
[The effect of fenspiride on the number of exacerbations and the time of first exacerbation in patients with chronic bronchitis].
PubMed·2005
PCVI8 COSTS OF HYPERTENSION IN THE ELDERLY IN COMPARISON WITH PATIENTS UNDER 65 IN POLAND
Value in Health·2004· 1 citedOpen Access
PCVI7 COSTS OF HYPERTENSION IN POLAND MEASURED FROM THE THIRD PARTY PAYER PERSPECTIVE IN COMPARISON WITH THE SOCIETAL PERSPECTIVE
Value in Health·2004
PDB18 SEARCHING FOR DIABETES MELLITUS (DM) IN PRIMARY CARE—IT IS GOOD VALUE-FOR-MONEY IN POLAND? (COST OF DIAGNOSING DIABETES MELLITUS IN PRIMARY CARE CONDITION IN POLAND)
Value in Health·2004Open Access
PCV20 COST EFFECTIVENESS OF ANTIHYPERTENSIVE MONO-THERAPYWITH PERINDOPRIL OR ENALAPRIL IN ELDERLY PATIENTS FROM THE THIRD PARTY PAYER PERSPECTIVE
Value in Health·2004· 1 cited
P-457 Effect of low dose combination of ACE-inhibitor and diuretic on the ventricular repolarization in the patients with hypertension
EP Europace·2003Open Access
PWH3 PULSED OESTROGEN THERAPY WITH INTRANASAL 17-B OESTRADIOL IMPROVES WOMEN'S QUALITY OF LIFE IN THE EARLY POSTMENOPAUSAL PERIOD
Value in Health·2003
PCV79 DEVELOPMENT AND VALIDATION OF THE NEW HEALTH-RELATED QUALITY OF LIFE INSTRUMENT SPECIFIC TO PATIENTS WITH CORONARY ARTERY DISEASE (CAD) IN POLAND: POL-CAD
Value in Health·2003Open Access
Announcement
Respiration·2003Open Access
Effects of Almitrine Bismesylate on Arterial Blood Gases in Patients with Chronic Obstructive Pulmonary Disease and Moderate Hypoxaemia: A Multicentre, Randomised, Double-Blind, Placebo-Controlled Study
Respiration·2003· 16 cited
PCV23 PHARMACOECONOMIC COMPARISON OF THE ANTIHYPERTENSIVE TREATMENT WITH TWO DIFFERENT ANGIOTENSINE CONVERTING ENZYME INHIBITORS: PERINDOPRIL AND ENALAPRIL
Value in Health·2002Open Access
page 1 of 2Next →

Frequent Co-authors

Marcin Czech(19), R Jaworski(9), T Faluta(8), Tomasz Hermanowski(8), Hanna Szwed(4), Małgorzata Domżał-Bocheńska(4), Dorota Górecka(4), Radosław Jaworski(4), Krzysztof Szymczak(3), Andrzej Paradowski(3), Grzegorz Gajos(3), Grzegorz L. Kałuża(3), I Kulon(3), Anna Wątor-Brzezińska(3), Waldemar Elikowski(3), Maria Kuźniak(3), Paweł Śliwiński(3), G Pałasiewicz(3), Marta Kucharska(3), W Bartminski(3)